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The Human Cell Atlas
Abstract The recent advent of methods for high-throughput single-cell molecular profiling has catalyzed a
growing sense in the scientific community that the time is ripe to complete the 150-year-old effort to identify all
cell types in the human body. The Human Cell Atlas Project is an international collaborative effort that aims to
define all human cell types in terms of distinctive molecular profiles (such as gene expression profiles) and to
connect this information with classical cellular descriptions (such as location and morphology). An open
comprehensive reference map of the molecular state of cells in healthy human tissues would propel the systematic
study of physiological states, developmental trajectories, regulatory circuitry and interactions of cells, and also
provide a framework for understanding cellular dysregulation in human disease. Here we describe the idea, its
potential utility, early proofs-of-concept, and some design considerations for the Human Cell Atlas, including a
commitment to open data, code, and community.
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Introduction
The cell is the fundamental unit of living organ-
isms. Hooke reported the discovery of cells in
plants in 1665 (Hooke, 1665) and named them
for their resemblance to the cells inhabited by
monks, but it took nearly two centuries for biolo-
gists to appreciate their central role in biology.
Between 1838 and 1855, Schleiden, Schwann,
Remak, Virchow and others crystalized an ele-
gant Cell Theory (Harris, 2000), stating that all
organisms are composed of one or more cells;
that cells are the basic unit of structure and func-
tion in life; and that all cells are derived from
pre-existing cells (Mazzarello, 1999; Figure 1).
To study human biology, we must know our
cells. Human physiology emerges from normal
cellular functions and intercellular interactions.
Human disease entails the disruption of these
processes and may involve aberrant cell types
and states, as seen in cancer. Genotypes give
rise to organismal phenotypes through the inter-
mediate of cells, because cells are the basic
functional units, each regulating their own pro-
gram of gene expression. Therefore, genetic var-
iants that contribute to disease typically manifest
their action through impact in a particular cell
types: for example, genetic variants in the IL23R
locus increase risk of autoimmune diseases by
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altering the function of dendritic cells and T-cells
(Duerr et al., 2006), and DMD mutations cause
muscular dystrophy through specific effects in
skeletal muscle cells (Murray et al., 1982).
For more than 150 years, biologists have
sought to characterize and classify cells into dis-
tinct types based on increasingly detailed
descriptions of their properties, including their
shape, their location and relationship to other
cells within tissues, their biological function, and,
more recently, their molecular components. At
every step, efforts to catalog cells have been
driven by advances in technology. Improvements
in light microscopy were obviously critical. So
too was the invention of synthetic dyes by chem-
ists (Nagel, 1981), which biologists rapidly
found stained cellular components in different
ways (Stahnisch, 2015). In pioneering work
beginning in 1887, Santiago Ramo´n y Cajal
applied a remarkable staining process
discovered by Camillo Golgi to show that the
brain is composed of distinct neuronal cells,
rather than a continuous syncytium, with stun-
ningly diverse architectures found in specific
anatomical regions (Ramon y Cajal, 1995); the
pair shared the 1906 Nobel Prize in Physiology
or Medicine for their work.
Starting in the 1930s, electron microscopy
provided up to 5000-fold higher resolution, mak-
ing it possible to discover and distinguish cells
based on finer structural features. Immunohis-
tochemistry, pioneered in the 1940s
(Arthur, 2016) and accelerated by the advent of
monoclonal antibodies (Ko¨hler and Milstein,
1975) and Fluorescence-Activated Cell Sorting
(FACS; Dittrich and Go¨hde, 1971; Fulwy-
ler, 1965) in the 1970s, made it possible to
detect the presence and levels of specific pro-
teins. This revealed that morphologically indis-
tinguishable cells can vary dramatically at the
molecular level and led to exceptionally fine
classification systems, for example, of hemato-
poietic cells, based on cell-surface markers. In
the 1980s, Fluorescence in situ Hybridization
(FISH; Langer-Safer et al., 1982) enhanced the
ability to characterize cells by detecting specific
DNA loci and RNA transcripts. Along the way,
studies showed that distinct molecular pheno-
types typically signify distinct functionalities.
Through these remarkable efforts, biologists
have achieved an impressive understanding of
specific systems, such as the hematopoietic and
immune systems (Chao et al., 2008; Jojic et al.,
2013; Kim and Lanier, 2013) or the neurons in
the retina (Sanes and Masland, 2015).
Despite this progress, our knowledge of cell
types remains incomplete. Moreover, current
classifications are based on different criteria,
such as morphology, molecules and function,
which have not always been related to each
other. In addition, molecular classification of
cells has largely been ad hoc – based on markers
discovered by accident or chosen for conve-
nience – rather than systematic and comprehen-
sive. Even less is known about cell states and
their relationships during development: the full
lineage tree of cells from the single-cell zygote
to the adult is only known for the nematode C.
elegans, which is transparent and has just ~1000
cells.
At a conceptual level, one challenge is that
we lack a rigorous definition of what we mean
by the intuitive terms ’cell type’ and ’cell state’.
Human
Gastrointestinal system
Intestinal
epithelial cells
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Small intestine
Figure 1. A hierarchical view of human anatomy. A graphical depiction of the anatomical
hierarchy from organs (such as the gut), to tissues (such as the epithelium in the crypt in the
small intestine), to their constituent cells (such as epithelial, immune, stromal and neural
cells).
DOI: https://doi.org/10.7554/eLife.27041.002
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Cell type often implies a notion of persistence
(e.g., being a hepatic stellate cell or a cerebellar
Purkinje cell), while cell state often refers to
more transient properties (e.g., being in the G1
phase of the cell cycle or experiencing nutrient
deprivation). But, the boundaries between these
concepts can be blurred, because cells change
over time in ways that are far from fully under-
stood. Ultimately, data-driven approaches will
likely refine our concepts.
The desirability of having much deeper
knowledge about cells has been well recognized
for a long time (Brenner, 2010; Eberwine et al.,
1992; Shapiro, 2010; Van Gelder et al., 1990).
However, only in the past few years has it begun
to seem feasible to undertake the kind of sys-
tematic, high-resolution characterization of
human cells necessary to create a systematic cell
atlas.
The key has been the recent ability to apply
genomic profiling approaches to single cells. By
’genomic approaches’ we mean methods for
large-scale profiling of the genome and its prod-
ucts, including DNA sequence, chromatin archi-
tecture, RNA transcripts, proteins, and
metabolites (Lander, 1996). It has long been
appreciated that such methods provide rich and
comprehensive descriptions of biological pro-
cesses. Historically, however, they could only be
applied to bulk tissue samples comprised of an
ensemble of many cells, providing average
genomic measures for a sample, but masking
their differences across cells. The result is as
unsatisfying as trying to understand New York,
London or Mumbai based on the average prop-
erties of their inhabitants.
The first single-cell genomic characterization
method to become feasible at large-scale is
trancriptome analysis by single cell RNA-Seq
(Box 1; Hashimshony et al., 2012; Jaitin et al.,
2014; Picelli et al., 2013; Ramsko¨ld et al.,
2012; Shalek et al., 2013). Initial efforts first
used microarrays and then RNA-seq to profile
RNA from small numbers of single cells, which
were obtained either by manual picking from in
situ fixed tissue, using flow-sorting or, later on,
with microfluidic devices, adapted from devices
developed initially for qPCR-based approaches
(Crino et al., 1996; Dalerba et al., 2011;
Marcus et al., 2006; Miyashiro et al., 1994;
Zhong et al., 2008). Now, massively parallel
assays can process tens and hundreds of thou-
sands of single cells simultaneously to measure
their transcriptional profiles at rapidly decreas-
ing costs (Klein et al., 2015; Macosko et al.,
2015; Shekhar et al., 2016) with increasing
accuracy and sensitivity (Svensson et al., 2017;
Ziegenhain et al., 2017). In some cases, it is
even possible to register these sorted cells to
their spatial positions in images (Vickovic et al.,
2016). Single-cell RNA sequencing (scRNA-seq)
is rapidly becoming widely disseminated.
Following this initial wave of technologies are
many additional methods at various stages of
development and high-throughput implementa-
tion. Techniques are being developed to assay:
in situ gene expression in tissues at single-cell
and even sub-cellular resolution (Chen et al.,
2015b; Ke et al., 2013; Lee et al., 2014;
Lubeck et al., 2014; Shah et al., 2016;
Sta˚hl et al., 2016); the distribution of scores of
proteins at cellular or sub-cellular resolution
(Angelo et al., 2014; Chen et al., 2015a;
Giesen et al., 2014; Hama et al., 2011;
Susaki et al., 2014; Yang et al., 2014); various
aspects of chromatin state (Buenrostro et al.,
2015; Cusanovich et al., 2015; Farlik et al.,
2015; Guo et al., 2013; Lorthongpanich et al.,
2013; Mooijman et al., 2016; Rotem et al.,
2015a; Rotem et al., 2015b; Smallwood et al.,
2014); and DNA mutations to allow precise
reconstruction of cell lineages (Behjati et al.,
2014; Biezuner et al., 2016; Shapiro et al.,
2013; Taylor et al., 2003; Teixeira et al.,
2013). Various groups are also developing sin-
gle-cell multi-omic methods to simultaneously
measure several types of molecular profiles in
the same cell (Albayrak et al., 2016;
Angermueller et al., 2016; Behjati et al., 2014;
Darmanis et al., 2016; Dey et al., 2015;
Frei et al., 2016; Genshaft et al., 2016;
Macaulay et al., 2015).
As a result, there is a growing sense in the
scientific community that the time is now right
for a project to complete the Human Cell Atlas
that pioneering histologists began 150 years
ago. Various discussions have taken place in a
number of settings over the past two years, cul-
minating in an international meeting in London
in October 2016. In addition, several pilot efforts
are already underway or in planning – for exam-
ple, related to brain cells and immune cells.
Prompted by such efforts, funding agencies,
including the NIH, have sought information from
the scientific community about the notion of cre-
ating cell or tissue atlases.
The goal of this article is to engage the wider
scientific community in this conversation.
Although the timing is driven by technologies
that have recently appeared or are expected to
mature in the near-future, the project itself is
fundamentally an intellectual endeavor. We
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Box 1: Key experimental methods for single-cell genomics
Over the past several years, powerful approaches have emerged that make it possible to mea-
sure molecular profiles and signatures at single-cell resolution. The field remains very active, with
new methods being rapidly developed and existing ones improved.
Single-cell RNA-Seq (scRNA-seq) refers to a class of methods for profiling the transcriptome of
individual cells. Some may take a census of mRNA species by focusing on 3’- or 5’-ends
(Islam et al., 2014; Macosko et al., 2015), while others assess mRNA structure and splicing by
collecting near-full-length sequence (Hashimshony et al., 2012; Ramsko¨ld et al., 2012). Strate-
gies for single-cell isolation span manual cell picking, initially used in microarray studies
(Eberwine et al., 1992; Van Gelder et al., 1990), FACS-based sorting into multi-well plates
(Ramsko¨ld et al., 2012; Shalek et al., 2013), microfluidic devices (Shalek et al., 2014;
Treutlein et al., 2014), and, most recently, droplet-based (Klein et al., 2015; Macosko et al.,
2015) and microwell-based (Fan et al., 2015; Yuan and Sims, 2016) approaches. The droplet
and microwell approaches, which are currently coupled to 3’-end counting, have the largest
throughput, allowing rapid processing of tens of thousands of cells simultaneously in a single
sample. scRNA-seq is typically applied to freshly dissociated tissue, but emerging protocols use
fixed cells (Nichterwitz et al., 2016; Thomsen et al., 2016) or nuclei isolated from frozen or
lightly fixed tissue (Habib et al., 2016b; Lake et al., 2016). Applications to fixed or frozen sam-
ples would simplify the process flow for scRNA-seq, as well as open the possibility of using archi-
val material. Power analyses provides a framework for comparing the sensitivity and accuracy of
these approaches (Svensson et al., 2017; Ziegenhain et al., 2017). Finally, there has been prog-
ress in scRNA-Seq with RNA isolated from live cells in their natural microenvironment using tran-
scriptome in vivo analysis (Lovatt et al., 2014).
Mass cytometry (CyTOF) and related methods allow multiplexed measurement of proteins
based on antibodies barcoded with heavy metals (Bendall et al., 2014; Levine et al., 2015). In
contrast to comprehensive profiles, these methods invglve pre-defined signatures and require
an appropriate antibody for each target, but they can process many millions of cells for a very
low cost per cell. They are applied to fixed cells. Recently, the approach has been extended to
the measurement of RNA signatures through multiplex hybridization of nucleic-acid probes
tagged with heavy metals (Frei et al., 2016).
Single-cell genome and epigenome sequencing characterizes the cellular genome. Genomic
methods aim either to characterize the whole genome or capture specific pre-defined regions
(Gao et al., 2016). Epigenomic methods may capture regions based on distinctive histone modi-
fications (single-cell ChIP-Seq; Rotem et al., 2015a), accessibility (single-cell ATAC-Seq;
Buenrostro et al., 2015; Cusanovich et al., 2015), or likewise characterize DNA methylation
patterns (single-cell DNAme-Seq; Farlik et al., 2015; Guo et al., 2013; Mooijman et al., 2016;
Smallwood et al., 2014) or 3D organization (single-cell Hi-C; Nagano et al., 2013;
Ramani et al., 2017). Combinatorial barcoding strategies have been used to capture measures
of accessibility and 3D organization in tens of thousands of single cells (Cusanovich et al., 2015;
Ramani et al., 2017). Single cell epigenomics methods are usually applied to nuclei, and can
thus use frozen or certain fixed samples. Some methods, such as single-cell DNA sequencing,
are currently applied to relatively few cells, due to the size of the genome and the sequencing
depth required. Other methods, such as single-cell analysis of chromatin organization (by either
single-cell ATAC-Seq; Buenrostro et al., 2015; Cusanovich et al., 2015) or single-cell ChIP-Seq
(Rotem et al., 2015a), currently yield rather sparse data, which presents analytic challenges and
benefits from large numbers of profiled cells. Computational analyses have begun to address
these issues by pooling of signal across cells and across genomic regions or loci
(Buenrostro et al., 2015; Rotem et al., 2015a) and by imputation (Angermueller et al., 2016).
Single-cell multi-omics techniques aim to collect two or more types of data (transcriptomic,
genomic, epigenomic, and proteomic) from the same single cell. Recent studies have simulta-
neously profiled the transcriptome together with either the genome (Angermueller et al., 2016;
Dey et al., 2015; Macaulay et al., 2015), the epigenome (Angermueller et al., 2016), or pro-
tein signatures (Albayrak et al., 2016; Darmanis et al., 2016; Frei et al., 2016; Genshaft et al.,
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therefore articulate the concept of a cell atlas
and explore its potential utility for biology and
medicine. We discuss how an atlas can lead to
new understanding of histology, development,
physiology, pathology, and intra- and inter-cellu-
lar regulation, and enhance our ability to predict
the impact of perturbations on cells. It will also
yield molecular tools with applications in both
research and clinical practice.
As discussed below, a Human Cell Atlas Proj-
ect would be a shared international effort involv-
ing diverse scientific communities. More details
are available in the Human Cell Atlas White
Paper (https://www.humancellatlas.org/files/
HCA_WhitePaper_18Oct2017.pdf): the first
version of this ’living document’, which will
updated on a regular basis, was released on
October 18, 2017.
What is the Human Cell Atlas, and
what could we learn from it?
At its most basic level, the Human Cell Atlas
must include a comprehensive reference catalog
of all human cells based on their stable proper-
ties and transient features, as well as their loca-
tions and abundances. Yet, an atlas is more than
just a catalog: it is a map that aims to show the
relationships among its elements. By doing so, it
can sometimes reveal fundamental processes –
2016). Efforts to combine three and more approaches are underway (Cheow et al., 2016).
Multi-omic methods could help fill in causal chains from genetic variation to regulatory mecha-
nisms and phenotypic outcome in health and in disease, especially cancer.
Multiplex in situ analysis and other spatial techniques aim to detect a limited number of
nucleic acids and/or proteins in situ in tissue samples – by hybridization (for RNA), antibody
staining (for proteins), sequencing (for nucleic acids), or other tagging strategies. These in situ
results can then be used to map massive amounts of single-cell genomic information from disso-
ciated cells onto the tissue samples providing important clues about spatial relationships and
cell-cell communication. Some strategies for RNA detection, such as MERFISH (Chen et al.,
2015b; Moffitt et al., 2016b) or Seq-FISH (Shah et al., 2016), combine multiplex hybridization
with microscopy-based quantification to assess distributions at both the cellular and subcellular
level; other early studies have performed in situ transcription (Tecott et al., 1988), followed by
direct manual harvesting of cDNA from individual cells (Crino et al., 1996; Tecott et al., 1988).
Some approaches for protein detection, such as Imaging Mass Cytometry (Giesen et al., 2014)
and Mass Ion Bean Imaging (Angelo et al., 2014), involve staining a tissue specimen with anti-
bodies, each labeled with a barcode of heavy metals, and rastering across the sample to mea-
sure the proteins in each ’pixel’. This technique permits the reconstruction of remarkably rich
images. Finally, more recent studies have performed RNA-seq in situ in cells and in preserved tis-
sue sections (Ke et al., 2013; Lee et al., 2014). Many in situ methods can benefit from tissue
clearing and/or expansion to improve detection and spatial resolution (Chen et al., 2015a;
Chen et al., 2016a; Moffitt et al., 2016a; Yang et al., 2014). The complexity and accuracy of
these methods continues to improve with advances in sample handling, chemistry and imaging.
Various methods are also used, for example, to measure transcriptomes in situ with barcoded
arrays (Sta˚hl et al., 2016).
Cell lineage determination Because mammals are not transparent and have many billions of
cells, it is not currently possible to directly observe the fate of cells by microscopy. Various alter-
native approaches have been developed (Kretzschmar and Watt, 2012). In mice, cells can be
genetically marked with different colors (Barker et al., 2007) or DNA barcodes (Lu et al., 2011;
Naik et al., 2013; Perie´ and Duffy, 2016), and their offspring traced during development.
Recent work has used iterative CRISPR-based genome editing to generate random genetic scars
in the fetal genome and use them to reconstruct lineages in the adult animal (McKenna et al.,
2016). In humans, where such methods cannot be applied, human cell lineages can be moni-
tored experimentally in vitro, or by transplantation of human cells to immunosuppressed mice
(Morton and Houghton, 2007; O’Brien et al., 2007; Richmond and Su, 2008), or can be
inferred from in vivo samples by measuring the DNA differences between individual sampled
cells, arising from random mutations during cell division, and using the genetic distances to con-
struct cellular phylogenies, or lineages (Behjati et al., 2014; Shapiro et al., 2013).
DOI: https://doi.org/10.7554/eLife.27041.003
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akin to how the atlas of Earth suggested conti-
nental drift through the correspondence of
coastlines.
To be useful, an atlas must also be an
abstraction, comprehensively representing cer-
tain features, while ignoring others. The writer
Jorge Luis Borges – a master at capturing the
tension between grandeur and grandiosity – dis-
tilled this challenge in his one-paragraph story,
"On Exactitude in Science", about an empire
enamored with science of cartography (Box 2;
Borges and Hurley, 2004). Over time, the car-
tographers’ map of the realm grew more and
more elaborate, and hence bigger, until –
expandio ad absurdum – the map reached the
size of the entire empire itself and became
useless.
Moreover, an atlas must provide a system of
coordinates on which one can represent and har-
monize concepts at many levels (geopolitical
borders, topography, roads, climate, restau-
rants, and even dynamic traffic patterns). Fea-
tures can be viewed at any level of
magnification, and high-dimensional information
collapsed into simpler views.
So, a key question is how a Human Cell Atlas
should abstract key features, provide coordi-
nates, and show relationships. A natural solution
would be to describe each human cell by a
defined set of molecular markers. For example,
one might describe each cell by the expression
level of each of the ~20,000 human protein-cod-
ing genes: that is, each cell would be repre-
sented as a point in ~20,000-dimensional space.
Of course, the set of markers could be
expanded to include the expression levels of
non-coding genes, the levels of the alternatively
spliced forms of each transcript, the chromatin
state of every promoter and enhancer, and the
levels of each protein or each post-translation-
ally modified form of each protein. The optimal
amount and type of information to collect will
emerge based on a balance of technological fea-
sibility and the biological insight provided by
each layer (Corces et al., 2016;
Lorthongpanich et al., 2013; Paul et al., 2015).
For specific applications, it will be useful to
employ reduced representations. Solely for con-
creteness, we will largely refer below to the
20,000-dimensional space of gene expression,
which can already be assayed at high-
throughput.
The Atlas should have additional coordinates
or annotations to represent histological and ana-
tomical information (e.g., a cell’s location, mor-
phology, or tissue context), temporal
information (e.g., the age of the individual or
time since an exposure), and disease status.
Such information is essential for harmonizing
results based on molecular profiles with rich
knowledge about cell biology, histology and
function. How best to capture and represent this
information requires serious attention.
In some respects, the Human Cell Atlas Proj-
ect (whose fundamental unit is a cell) is analo-
gous to the Human Genome Project (whose
fundamental unit is a gene). Both are ambitious
efforts to create ’Periodic Tables’ for biology
Box 2: On Exactitude in Science. Jorge Luis Borges (1946)
“.. . In that Empire, the Art of Cartography attained such Perfection that the map of a single
Province occupied the entirety of a City, and the map of the Empire, the entirety of a Province.
In time, those Unconscionable Maps no longer satisfied, and the Cartographers Guilds struck a
Map of the Empire whose size was that of the Empire, and which coincided point for point with
it. The following Generations, who were not so fond of the Study of Cartography as their Fore-
bears had been, saw that that vast map was Useless, and not without some Pitilessness was it,
that they delivered it up to the Inclemencies of Sun and Winters. In the Deserts of the West, still
today, there are Tattered Ruins of that Map, inhabited by Animals and Beggars; in all the Land
there is no other Relic of the Disciplines of Geography.”
Purportedly from Sua´rez Miranda, Travels of Prudent Men, Book Four, Ch. XLV, Le´rida, 1658.
Ó 1998 Maria Kodama; translation Ó 1998 Penguin Random House LLC. "On Exactitude in Sci-
ence" from Collected Fictions: Volume 3 by Jorge Luis Borges, translated by Andrew Hurley.
Used by permission of Viking Books, an imprint of Penguin Publishing Group, a division of Pen-
guin Random House LLC. All rights reserved.
DOI: https://doi.org/10.7554/eLife.27041.004
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that comprehensively enumerate the two key
’atomic’ units that underlie human life (cells and
genes) and thereby provide a crucial foundation
for biological research and medical application.
As with the Human Genome Project, we will also
need corresponding atlases for important model
organisms, where conserved cell states can be
identified and genetic manipulations and other
approaches can be used to probe function and
lineage. Yet, the Human Cell Atlas differs in
important ways from the Human Genome Proj-
ect: the nature of cell biology means that it will
require a distinct experimental toolbox, and will
involve making choices concerning molecular
and cellular descriptors. Assessing the distance
to completion will also be a challenge.
As a Borgesian thought experiment, we could
conceive of an imaginary Ultimate Human Cell
Atlas that represents: all markers in every cell in
a person’s body; every cell’s spatial position (by
adding three dimensions for the body axes);
every cell at every moment of a person’s lifetime
(by adding another dimension for time relating
the cells by a lineage); and the superimposition
of such cell atlases from every human being,
annotated according to differences in health,
genotype, lifestyle and environmental exposure.
Of course, it is not possible to construct such
an Ultimate Atlas. However, it is increasingly fea-
sible to sample richly from the distribution of
points to understand the key features and rela-
tionships among all human cells. We return
below to the question of how the scientific com-
munity might go about creating a Human Cell
Atlas. First, we consider the central scientific
question: What could we hope to learn from
such an atlas?
A Human Cell Atlas would have a profound
impact on biology and medicine by bringing our
understanding of anatomy, development, physi-
ology, pathology, intracellular regulation, and
intercellular communication to a new level of res-
olution. It would also provide invaluable
markers, signatures and tools for basic research
(facilitating detection, purification and genetic
manipulation of every cell type) and clinical
applications (including diagnosis, prognosis and
monitoring response to therapy).
In the following sections, we outline reason-
able expectations and describe some early
examples. We recognize that these concepts will
evolve based on emerging data. It is clear that a
Human Cell Atlas Project will require and will
motivate the development of new technologies.
It will also necessitate the creation of new math-
ematical frameworks and computational
approaches that may have applications far
beyond biology – perhaps analogous to how
biological ’big data’ in agriculture in the 1920s
led to the creation, by R.A. Fisher and others, of
key statistical methods, including the analysis of
variance and experimental design
(Parolini, 2015).
Taxonomy: cell types
The most fundamental level of analysis is the
identification of cell types. In an atlas where cells
are represented as points in a high-dimensional
space, ’similar’ cells should be ’close’ in some
appropriate sense, although not identical, owing
to differences in physiological states (e.g., cell-
cycle stage), the inherent noise in molecular sys-
tems (Eldar and Elowitz, 2010;
Kharchenko et al., 2014; Kim et al., 2015;
Shalek et al., 2013), and measurement errors
(Buettner et al., 2015; Kharchenko et al.,
2014; Kim et al., 2015; Shalek et al., 2013;
Shalek et al., 2014; Wagner et al., 2016). Thus,
a cell ’type’ might be defined as a region or a
probability distribution (Kim and Eberwine,
2010; Sul et al., 2012) either in the full-dimen-
sional space or in a projection onto a lower-
dimensional space that reflects salient features.
While this notion is intuitively compelling, it is
challenging to give a precise definition of a ’cell
type’. Cell-type taxonomies are often repre-
sented as hierarchies based on morphological,
physiological, and molecular differences
(Sanes and Masland, 2015). Whereas higher
distinctions are easily agreed upon, finer ones
may be less obvious and may not obey a strict
hierarchy, either because distinct types share
features, or because some distinctions are
graded and not discrete. Critically, it remains
unclear whether distinctions based on morpho-
logical, molecular and physiological properties
agree with each other. New computational
methods will be required both to discover types
and to better classify cells and, ultimately, to
refine the concepts themselves (Gru¨n and van
Oudenaarden, 2015; Shapiro et al., 2013;
Stegle et al., 2015; Tanay and Regev, 2017;
Wagner et al., 2016). Unsupervised clustering
algorithms for high-dimensional data provide an
initial framework (Gru¨n et al., 2015; Gru¨n et al.,
2016; Jaitin et al., 2014; Levine et al., 2015;
Macosko et al., 2015; Shekhar et al., 2016;
Vallejos et al., 2015), but substantial advances
will be needed in order to select the ’right’ fea-
tures, the ’right’ similarity metric, and the ’right’
level of granularity for the question at hand,
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control for distinct biological processes, handle
technical noise, and connect novel clusters with
legacy knowledge. Whereas cell types are ini-
tially defined based on regions in feature space,
it will be important eventually to distill them into
simpler molecular and morphological signatures
that can be used to index cells in the atlas,
aggregate and compare results from indepen-
dent labs and different individuals, and create
tools and reagents for validation and follow up
studies.
For all the reasons above, we have not
attempted to propose a precise definition of
’cell type’. Rather, the definition should evolve
based on empirical observation.
Despite these challenges, recent studies in
diverse organs – including immune, nervous, and
epithelial tissues – support the prospects for
comprehensive discovery of cell types, as well as
harmonization of genomic, morphological, and
functional classifications (Figure 2A–C). For
example, analysis of immune cells from mouse
spleen (Jaitin et al., 2014) and human blood
(Horowitz et al., 2013) showed that well-estab-
lished functional immune cell types and subtypes
could be readily distinguished by unsupervised
clustering of single-cell expression profiles. Simi-
larly, single-cell expression profiles of epithelial
cells from gut organoids (Gru¨n et al., 2015) dis-
tinguished known cell subtypes, each with dis-
tinctive functional and histological
characteristics, while also revealing a new sub-
type of enteroendocrine cells, which was subse-
quently validated experimentally.
The nervous system, where many cell types
have not yet been characterized by any means,
illustrates both the promise and the challenge.
Whereas each of the 302 individual neurons in
C. elegans can be distinctly defined by its line-
age, position, connectivity, molecular profile and
functions, the extent to which the ~ 1011 neurons
in the human brain are distinctly defined by mor-
phological, physiological, lineage, connectivity,
and electrical-activity criteria, and have distinct
molecular profiles, remains unknown. Cellular
neuroanatomy is deeply rooted in the concept
of cell types defined by their morphologies (a
proxy for connectivity) and electrophysiological
properties (Ascoli et al., 2008), and extensive
efforts continue to classify the types in compli-
cated structures like the retina and neocortex
(Jiang et al., 2015; Markram et al., 2015;
Sanes and Masland, 2015). Critically, it remains
unclear whether distinctions based on morpho-
logical, connectional, and physiological proper-
ties agree with their molecular properties.
The mouse retina provides an ideal testing
ground to test this correspondence because cell
types follow highly stereotyped spatial patterns
(Macosko et al., 2015; Sanes and Masland,
2015). Analysis of 31,000 retinal bipolar cells
(Shekhar et al., 2016) automatically re-discov-
ered the 13 subtypes that had been defined
over the past quarter-century based on mor-
phology and lamination, while also revealing two
new subtypes with distinct morphological and
laminar characteristics. These subtypes included
one with a ’bipolar’ expression pattern and
developmental history, but a unipolar morphol-
ogy in the adult (Shekhar et al., 2016), which
has distinct functional characteristics in the neu-
ral circuits of the retina (Della Santina et al.,
2016). In this example, known morphological
and other non-molecular classifications matched
perfectly to molecular types, and new molecu-
larly-defined cell types discovered in the single-
cell transcriptomic analysis corresponded to
unique new morphology and histology. In other
complex brain regions such as the neocortex
and hippocampus there are also a large number
of transcriptionally defined types
(Darmanis et al., 2015; Gokce et al., 2016;
Habib et al., 2016a; Lake et al., 2016;
Pollen et al., 2014; Tasic et al., 2016;
Zeisel et al., 2015), but it has been more diffi-
cult to find consensus between data modalities,
and the relationship between transcriptomic
types and anatomical or morphological types is
unclear. In this light, technologies that can
directly measure multiple cellular phenotypes
are essential. For example, electrophysiological
measurements with patch clamping followed by
scRNA-seq used in a recent study of a particular
inhibitory cortical cell type showed that the tran-
scriptome correlated strongly with the cell’s
physiological state (Cadwell et al., 2016;
Fo¨ldy et al., 2016). Thus, the transcriptome
appears to provide a proxy for other neuronal
properties, but much more investigation is
needed.
Histology: cell neighborhood and
position
Histology examines the spatial position of cells
and molecules within tissues. Over the past cen-
tury, we have learnt a great deal about cell
types, markers, and tissue architecture, and this
body of knowledge will need to be further
refined and woven seamlessly into the Human
Cell Atlas. With emerging highly multiplexed
methods for in situ hybridization (Chen et al.,
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2015b; Shah et al., 2016) or protein staining
(Angelo et al., 2014; Giesen et al., 2014), it
should be possible to spatially map multiple cell
types at once based on expression signatures to
see how they relate to each other and to con-
nect them with cell types defined by morphol-
ogy or function. It should also be possible to
extend observations of continuous gradients for
individual genes (such as morphogens) to multi-
gene signatures.
Computational approaches could then allow
iterative refinement of cellular characterization
based on both a cell’s molecular profile and
information about its neighborhood; methods
perfected in the analysis of networks could pro-
vide a helpful starting point (Blondel et al.,
2008; Rosvall and Bergstrom, 2008). Con-
versely, expression data from a cell can help
map its position in absolute coordinates or rela-
tive terms, as well as in the context of pathol-
ogy, highlighting how disease tissue differs from
typical healthy tissue. Combining molecular pro-
files with tissue architecture will require new
computational methods, drawing perhaps on
Figure 2. Anatomy: cell types and tissue structure. The first three plots show single cells (dots) embedded in low-
dimensional space based on similarities between their RNA-expression profiles (A, C) or protein-expression
profiles (B), using either t-stochastic neighborhood embedding (A,B) or circular projection (C) for dimensionality
reduction and embedding. (A) Bi-polar neurons from the mouse retina. (B) Human bone marrow immune cells. (C)
Immune cells from the mouse spleen. (D) Histology. Projection of single-cell data onto tissue structures: image
shows the mapping of individual cells onto locations in the marine annelid brain, based on the correspondence
(color bar) between their single-cell expression profiles and independent FISH assays for a set of landmark
transcripts.
Ó 2016 Elsevier Inc. Figure 2A reprinted from Shekhar et al., 2016 with permission.
Ó 2015 Elsevier Inc. Figure 2B reprinted from Levine et al., 2015 with permission.
Ó 2014 AAAS. Figure 2C reprinted from Jaitin et al., 2014 with permission.
Ó 2015 Macmillan Publishers Limited. Figure 2D adapted from Achim et al., 2015 with permission.
DOI: https://doi.org/10.7554/eLife.27041.005
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advances in machine vision (Xu et al., 2015;
Zheng et al., 2015).
New methods for integrating single-cell
genomics data into a spatial context have been
developed recently. Single-cell analyses of tis-
sues from early embryos (Satija et al., 2015;
Scialdone et al., 2016) to adult (Achim et al.,
2015) demonstrate how physical locations can
be imprinted in transcriptional profiles (Durru-
thy-Durruthy et al., 2014) and can be used to
infer tissue organization (Figure 2D). In the early
zebrafish embryo, for example, a cell’s expres-
sion profile specifies its location to within a small
neighborhood of ~100 cells; the related expres-
sion patterns of individual genes in turn fall into
only nine spatial archetypes (Satija et al., 2015).
In the early mouse embryo, key spatial gradients
can be recovered by a ’pseudospace’ inferred
from reduced dimensions of single cell profiles
(Scialdone et al., 2016). In adult mouse hippo-
campus, cell profiles show clear clusters corre-
sponding to discrete functional regions as well
as gradients following dorsal/ventral and
medial/lateral axes (Habib et al., 2016a). In the
annelid brain, even finer punctate spatial pat-
terns can be resolved (Achim et al., 2015).
Development: transitions to
differentiated cell types
Cells arrive at their final differentiated cell types
through partly asynchronous branching path-
ways of development (Ferrell, 2012), which are
driven by and reflected in molecular changes,
especially gene-expression patterns (see, for
example, Chao et al., 2008; Jojic et al., 2013).
It should therefore be possible to reconstruct
development as trajectories in high-dimensional
space, mirroring Waddington’s landscape (Fer-
rell, 2012; Waddington, 1957) – just as it would
be possible to infer the ski lifts and trails on a
mountain from snapshots of the positions of
enough skiers. One can even infer sharp transi-
tions, provided enough cells are observed. The
required sampling density will depend on the
number and complexity of paths and intersec-
tions, and sorting strategies can help to itera-
tively enrich for rare, transient populations.
Notably, the relative proportions of cells
observed at different points along the develop-
mental paths can help convey critical informa-
tion, both about the duration of each phase
(Antebi et al., 2013; Kafri et al., 2013) and the
balance of how progenitor cells are allocated
among fates (Antebi et al., 2013;
Lo¨nnberg et al., 2017; Moris et al., 2016),
especially when information about the rate of
cell proliferation and/or death can be incorpo-
rated as inferred from the profiles.
In animal models, it should be possible to cre-
ate true lineage trees by marking a common
progenitor cell type. For example, one might
use synthetic circuits that introduce a molecular
barcode only in cells expressing an RNA pattern
characteristic of the cell type in order to recog-
nize its descendants (Gagliani et al., 2015;
McKenna et al., 2016). In humans, immune cells
naturally contain lineage barcodes through VDJ
recombination in T and B cells and somatic
hypermutation in B cells (Stubbington et al.,
2016). More generally, it may be feasible to
accomplish lineage tracing in human cells by tak-
ing advantage of the steady accumulation of
DNA changes (such as somatic point mutations,
or repeat expansions at microsatellite loci) at
each cell division (Behjati et al., 2014;
Biezuner et al., 2016; Martincorena et al.,
2015; Reizel et al., 2012; Shlush et al., 2012)
or as a molecular clock (Taylor et al., 2003;
Teixeira et al., 2013).
Initial computational methods have already
been developed for inferring dynamic trajecto-
ries from large numbers of single-cell profiles,
although better algorithms are still needed. Crit-
ical challenges include accurately inferring
branching structures, where two or more paths
diverge from a single point; reconstructing ’fast’
transitions, where only few cells can be cap-
tured; and accounting for the fact that a cell may
be following multiple dynamic paths simulta-
neously – for example, differentiation, the cell
cycle, and pathogen response (see below) – that
may affect each other. The reconstruction algo-
rithms themselves could incorporate insights
from theoretical studies of dynamical systems,
and learned models could be analyzed in light of
such frameworks (Ferrell, 2012; May, 1976;
Thom, 1989).
Recent studies provide proofs-of-principle for
how simultaneous and orthogonal biological
processes can be inferred from single-cell RNA-
seq data (Figure 3; Angerer et al., 2016;
Bendall et al., 2014; Chen et al., 2016b;
Haghverdi et al., 2015; Haghverdi et al., 2016;
Lo¨nnberg et al., 2017; Marco et al., 2014;
Moignard et al., 2015; Setty et al., 2016;
Trapnell et al., 2014; Treutlein et al., 2016).
Linear developmental trajectories have been
reconstructed, for example, from single-cell pro-
tein expression during B-cell differentiation
(Bendall et al., 2014), and from single-cell RNA
expression during myogenesis in vitro
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(Trapnell et al., 2014), early hematopoiesis
(Nestorowa et al., 2016), neurogenesis in vivo
(Habib et al., 2016a; Shin et al., 2015), and
reprogramming from fibroblasts to neurons
(Treutlein et al., 2016). With a large enough
number of cells, analysis of B-cell development
was able to highlight a rare (0.007%) population
corresponding to the earliest B-cell lymphocytes
and confirm the identification by reference to
rearrangements at the IgH locus. In direct
reprogramming to neurons, scRNA-seq revealed
unexpected trajectories (Treutlein et al., 2016).
Bifurcated trajectories have also been recon-
structed in the differentiation of embryonic stem
cells, T helper cells, and hematopoietic cells
(Chen et al., 2016b; Haghverdi et al., 2015;
Haghverdi et al., 2016; Lo¨nnberg et al., 2017;
Marco et al., 2014; Moignard et al., 2015;
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Figure 3. Developmental trajectories. Each plot shows single cells (dots; colored by trajectory assignment,
sampled time point, or developmental stage) embedded in low-dimensional space based on their RNA (A-C) or
protein (D) profiles, using different methods for dimensionality reduction and embedding: Gaussian process
patent variable model (A); t-stochastic neighborhood embedding (B, D); diffusion maps (C). Computational
methods then identify trajectories of pseudo-temporal progression in each case. (A) Myoblast differentiation in
vitro. (B) Neurogenesis in the mouse brain dentate gyrus. (C) Embryonic stem cell differentiation in vitro. (D) Early
hematopoiesis.
Ó 2017 AAAS. Figure 3A reprinted from Lo¨nnberg et al., 2017 with permission.
Ó 2016 AAAS. Figure 3B reprinted from Habib et al., 2016a with permission.
Ó 2016 Macmillan Publishers Limited. . Figure 3C adapted from Haghverdi et al., 2016 with permission.
Ó 2016 Macmillan Publishers Limited. Figure 3D adapted from Setty et al., 2016 with permission.
DOI: https://doi.org/10.7554/eLife.27041.006
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Setty et al., 2016), and have helped address
open questions about whether myeloid progeni-
tor cells in bone marrow are already skewed
towards distinct fates (Olsson et al., 2016;
Paul et al., 2015) and when T helper cell commit
to their fate (Lo¨nnberg et al., 2017).
Physiology and homeostasis:
cycles, transient responses and
plastic states
In addition to development and differentiation,
cells are constantly undergoing multiple dynamic
processes of physiological change and homeo-
static regulation (Yosef and Regev, 2011;
2016). These include cyclical processes, such as
the cell cycle and circadian rhythms; transient
responses to diverse factors, from nutrients and
microbes to mechanical forces and tissue dam-
age; and plastic states that can be stably main-
tained over longer time scales, but can change
in response to new environmental cues. (The
precise boundary between plastic states and cell
types, it must be noted, remains to be clarified.)
The molecular phenotype of a cell reflects a
superposition of these various processes and
their interactions (Wagner et al., 2016).
Studies of physiological processes from bulk
tissue samples are hampered by asynchrony and
heterogeneity among cells, which blur the sig-
nals of individual processes and states; investiga-
tors strive to create homogeneous cell
populations through synchronization and purifi-
cation. By contrast, single-cell analysis exploits
asynchrony and heterogeneity, leveraging varia-
tion within a cell population to reveal underlying
structures. The difference is analogous to two
approaches in structural biology: X-ray crystal-
lography, which requires molecules to be in a
crystalline order, and cryo-electron microscopy,
which depends on observing large numbers of
molecules in randomly sampled poses.
From asynchronous observations of cyclical
and transient processes, it should be possible to
’order’ cells with respect to the process (as for
development), with cell proportions reflecting
residence time (e.g., the length of a phase of
the cell cycle). As was initially shown for single-
cell measurement of a few features of the cell
cycle (Kafri et al., 2013), analysis of many sys-
tems could yield a near-continuous model of the
process, provided that a sufficient number of
cells is sampled. This can occur either because
all phases co-occur (e.g., in asynchronously
cycling cells) or because enough time points are
sampled to span the full process. If very rapid
and dramatic discontinuities exist, recovering
them would likely require direct tracing, for
example by genetic tracers or live analysis in cell
cultures, organoids, or animal models.
Once the cells are ordered, one can derive
gene-signatures that reflect each phase and use
them to further sharpen and refine the model.
With sufficient data, it should also be possible to
tease apart interactions among processes occur-
ring in parallel (such as the cell cycle, response
to a pathogen, and differentiation). For plastic
states, it may be possible to capture transient
transitions between them, especially if they can
be enriched by appropriate physiological cues.
Finally, we will likely learn about the nature of
stable states: while we often think of stable
states as discrete attractor basins (Wadding-
ton, 1957), there may also be troughs that
reflect a continuous spectrum of stable states (e.
g., the ratio of two processes may vary across
cells, but are stable in each; Antebi et al., 2013;
Gaublomme et al., 2015; Huang, 2012,
2013; Rebhahn et al., 2014; Zhou et al., 2012;
Zhou et al., 2016). Some key aspects of pro-
cesses may be difficult to uncover solely from
observations of transitions among molecular
states, and will likely require directed perturba-
tions and detailed mechanistic studies.
Recent studies have shown that cyclical pro-
cesses and transient responses – from the cell
cycle (Buettner et al., 2015; Gut et al., 2015;
Kafri et al., 2013; Kowalczyk et al., 2015;
Macosko et al., 2015; Proserpio et al., 2016;
Tirosh et al., 2016a) to the response of immune
cells to pathogen components (Avraham et al.,
2015; Shalek et al., 2013; Shalek et al., 2014)
– can be traced in single-cell profiles. It is possi-
ble to order the cells temporally, define coordi-
nately expressed genes with high precision,
identify the time scale of distinct phases, and
relate these findings to orthogonal measures
(Figure 4). For example, in the cell cycle, analy-
sis of single-cell profiles readily shows a robust,
reproducible and evolutionarily conserved pro-
gram that can be resolved in a near-continuous
way across human and mouse cell lines
(Macosko et al., 2015), primary immune cells
(Buettner et al., 2015; Kowalczyk et al., 2015),
and healthy and disease tissues (Patel et al.,
2014; Tirosh et al., 2016a; Tirosh et al.,
2016b). This approach has made it possible to
determine the relative rates of proliferation of
different cell subpopulations within a dataset
(Buettner et al., 2015; Kolodziejczyk et al.,
2015; Kowalczyk et al., 2015; Tsang et al.,
2015), a feat difficult to accomplish using bulk
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synchronized populations along the cell cycle
(Bar-Joseph et al., 2008; Lu et al., 2007). Nota-
bly, the cell cycle could also be reconstructed by
similar approaches when applied to imaging
data of very few molecular markers along with
salient spatial features (Gut et al., 2015) or with
morphology alone (Blasi et al., 2016;
Eulenberg et al., 2017). Similar principles apply
to transient responses. In the response of den-
dritic cells to pathogen components, single-cell
profiling uncovered a small subset (<1%) of ’pre-
cocious’ cells: these early-appearing cells
express a distinctive module of genes, initiate
production of interferon beta, and coordinate
the subsequent response of other cells through
paracrine signaling (Shalek et al., 2014).
Disease: cells and cellular
ecosystems
The Human Cell Atlas will be a critical reference
for studying disease, which invariably involves
disruption of normal cellular functions, interac-
tions, proportions, or ecosystems. The power of
single-cell analysis of disease is evident from
decades of histopathological studies and FACS
analysis. It will be substantially extended by the
routine ability to characterize cells and tissues
with rich molecular signatures, rather than focus-
ing on a limited number of pre-defined markers
or cell populations. It will also support the grow-
ing interest in understanding interactions
between frankly abnormal cells and all other
cells in a tissue’s ecosystem in promoting or sup-
pressing disease processes (e.g., between malig-
nant cells and the tumor microenvironment).
Single-cell analysis of disease samples will
also likely be critical to see the full range of nor-
mal cellular physiology, because disease either
elicits key perturbs cellular circuitry in informa-
tive ways. A clear example is the immune sys-
tem, where only in the presence of a ’challenge’
is the full range of appropriate physiological
behaviors and potential responses by a cell
revealed.
Single-cell information across many patients
will allow us to learn about how cell proportions
and states vary and how this variation correlates
with genome variants, disease course and treat-
ment response. From initial studies of a limited
number of patients, it should be possible to
derive signatures of key cell types and states
and use them to deconvolute cellular propor-
tions in conventional bulk-tissue or blood sam-
ples (Levine et al., 2015; Tirosh et al., 2016a).
Future studies may expand single-cell analysis to
thousands of patients to directly investigate how
genetic variation affects gene transcription and
regulation.
The hematopoietic system will be an early
and fruitful target. A study involving signatures
of cell-signaling assays by single-cell mass
cytometry of healthy hematopoietic cells led to
Figure 4. Physiology. Each plot shows single cells (dots) embedded in low-dimensional space on the basis of their RNA profile, based on predefined
gene signatures (A) or PCA (B, C), highlighting distinct dynamic processes. (A) The cell cycle in mouse hematopoietic stem and progenitor cells;
adapted under terms of CC BY 4.0 from Scialdone et al. (2015). (B) Response to lipopolysaccharide (LPS) in mouse immune dendritic cells. (C)
Variation in the extent of pathogenicity in mouse Th17 cells.
Ó 2014 Macmillan Publishers Limited. Figure 4B adapted from Shalek et al., 2014 with permission.
Ó 2015 Elsevier Inc. Figure 4C reprinted from Gaublomme et al., 2015 with permission.
DOI: https://doi.org/10.7554/eLife.27041.007
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more accurate classification of hematopoietic
stem and progenitor cells (HSPCs) in Acute Mye-
loid Leukemia; a previous classification was
error-prone, because the ’classical’ cell-surface
markers of healthy cells do not correctly identify
the corresponding population in disease,
whereas a richer signature allows accurate iden-
tification (Levine et al., 2015). Monitoring rare
immune populations first discovered in a normal
setting can help zero in on the relevant aberra-
tions in disease. For example, the rare popula-
tion associated with VDJ recombination first
identified by trajectory analysis of B cell devel-
opment (Bendall et al., 2014) is expanded in
pediatric Acute Lymphoblastic Leukemia, and
drastically more so in recurrence (Gary Nolan,
unpublished results).
The greatest impact, at least in the short
term, is likely to be in cancer. Early studies used
single-cell qPCR to investigate the origin of
radioresistance in cancer stem cells
(Diehn et al., 2009) and to dissect the heteroge-
neity and distortions of cellular hierarchy in colon
cancer (Dalerba et al., 2011). With the advent
of high-throughput methods, single-cell genome
analysis has been used to study the clonal struc-
ture and evolution of tumors in both breast can-
cer (Wang et al., 2014) and acute lymphoblastic
leukemia (Gawad et al., 2014), and to infer the
order of earliest mutations that cause acute
myeloid leukemia (Corces-Zimmerman et al.,
2014; Jan et al., 2012).
In recent studies of melanoma (Tirosh et al.,
2016a), glioblastoma (Patel et al., 2014), low-
grade glioma (Tirosh et al., 2016b), and myelo-
proliferative neoplasms (Kiselev et al., 2017),
single-cell RNA-seq of fresh tumors resected
directly from patients readily distinguished
among malignant, immune, stromal and endo-
thelial cells. Among the malignant cells, it identi-
fied distinct cell states – such as cancer stem
cells (Patel et al., 2014; Tirosh et al., 2016b),
drug-resistant states (Tirosh et al., 2016a), pro-
liferating and quiescent cells (Patel et al., 2014;
Tirosh et al., 2016a; Tirosh et al., 2016b) – and
related them to each other, showing, for exam-
ple, that only stem-like cells proliferate in low-
grade glioma (Tirosh et al., 2016b) and that
individual sub-clones can be readily identified in
one patient (Kiselev et al., 2017). Among the
non-malignant cells, it found distinct functional
states for T-cells, and revealed that, while activa-
tion and exhaustion programs are coupled, the
exhausted state is also controlled by an indepen-
dent regulatory program in both human tumors
(Tirosh et al., 2016a) and a mouse model
(Singer et al., 2016). To associate patterns
observed in a few (5-20) patients with effects on
clinical phenotypes, single-cell based signatures
were used to deconvolute hundreds of bulk
tumor profiles that had been collected with rich
clinical information (Levine et al., 2015;
Patel et al., 2014; Tirosh et al., 2016a).
Molecular mechanisms:
intracellular and inter-cellular
circuits
A Human Cell Atlas can also shed light on the
molecular mechanisms that control cell type, dif-
ferentiation, responses and states – within cells,
between cells, as well as between cells and their
tissue matrix.
For example, over the past several decades,
biologists have sought to infer the circuitry
underlying gene regulation by observing correla-
tions between the expression of particular regu-
lators and specific cellular phenotypes, drawing
inferences about regulation, and testing their
models through targeted genetic perturbations.
Single-cell data provide a massive increase not
only in the quantity of observations, but also in
the range of perturbations. The number of cells
profiled in a single-cell RNA-seq experiment can
far exceed the number of profiles produced
even by large consortia (such as ENCODE, FAN-
TOM, TCGA, and GTEx). Moreover, each single
cell is a perturbation system in which the levels
of regulatory molecules vary naturally – some-
times subtly, sometimes dramatically – due to
both stochastic and controlled phenomena
within a single genetic background, providing
rich information from which to reconstruct cellu-
lar circuits (Krishnaswamy et al., 2014;
Sachs et al., 2005; Shalek et al., 2013; Stew-
art-Ornstein et al., 2012).
Initial studies have shown that such analyses
can uncover intracellular regulators governing
cell differentiation and response to stimuli. For
example, co-variation of RNA levels across a
modest number of cells from a relatively ’pure’
population of immune dendritic cells responding
to a pathogen component was sufficient to con-
nect antiviral transcription factors to their target
genes, because of asynchrony in the responses
(Shalek et al., 2013). Similarly, co-variation anal-
ysis of a few hundred Th17 cells spanning a con-
tinuum from less to more pathogenic states
revealed regulators that control pathogenicity,
but not other features, such as cell differentia-
tion (Gaublomme et al., 2015). Co-variation
identified a role for pregnenolone biosynthesis
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in the response of Th2 cells to helminth infection
(Mahata et al., 2014), and new regulators of
pluripotency in mouse embryonic stem cells
(Kolodziejczyk et al., 2015). Computationally
ordering cells along a time-course of develop-
ment provides another way to infer regulators –
a strategy that has been successful in, for exam-
ple, differentiating B cells (Bendall et al., 2014),
myoblasts (Trapnell et al., 2014), neurons
(Habib et al., 2016a; Shin et al., 2015), and T
helper cells (Lo¨nnberg et al., 2017). Finally,
when circuitry is already known, variation across
single cells can be used to infer exquisite – and
functionally important – quantitative distinctions
about how signal is processed and propagated.
An elegant example is a recent analysis of signal-
ing pathways downstream from the T cell recep-
tor, where single-cell proteomics data has shown
how the same cellular circuitry processes signals
differently in naı¨ve and antigen-exposed T cells
(Krishnaswamy et al., 2014).
Beyond transcriptome analysis, single-cell
multi-omic profiles (Box 1) will improve the infer-
ence of cellular circuitry by connecting regula-
tory mechanisms and their targets (Tanay and
Regev, 2017). For example, simultaneous mea-
surement of chromatin accessibility and RNA lev-
els may help identify which regulatory regions –
and by inference which trans–acting regulators –
control the levels of which genes. Concomitant
measurement of DNA mutations and transcrip-
tional profiles in cancer cells may allow similar
causal connections to be drawn, as has been
recently shown for mutations in the CIC gene
and the expression of its regulatory targets
(Tirosh et al., 2016b).
Studies can be extended from naturally
occurring variation among cells to engineered
perturbations, by using pooled CRISPR libraries
to manipulate genes and reading out both the
perturbation and its effects on cellular pheno-
type in single cells – for example, by single-cell
RNA-Seq (Adamson et al., 2016; Dixit et al.,
2016; Jaitin et al., 2016).
A cell atlas can also help shed light on inter-
cellular communication, based on correlated
profiles across cell types and patients. For exam-
ple, analysis of single-cell profiles from many
small clusters of a few aggregated cells allowed
the construction of a cell-cell interaction network
in the bone marrow, uncovering specific interac-
tion between megakaryocytes and neutrophils,
as well as between plasma cells and neutrophil
precursors (Alexander van Oudenaarden, unpub-
lished results). Cell-cell interactomes have also
been inferred from profiles of purified cell
populations, based on the secreted and cell sur-
face molecules that they express
(Ramilowski et al., 2015).
In tumors from melanoma patients, gene-
expression analysis (involving single-cell data
obtained from some patients and bulk tumor
data from many more patients, deconvoluted
based on signatures learned from the single
cells) found genes that are expressed in one cell
type, but whose expression levels are correlated
with the proportion of a different cell type that
does not express them; this analysis revealed
that high expression of the complement system
in cancer-associated fibroblasts in the tumor
microenvironment is correlated with increased
infiltration of T cells (Tirosh et al., 2016a). Anal-
ysis of individual subcutaneous adipose stem
cells revealed the existence of a novel cell popu-
lation that negatively controls the differentiation
of the resident stem cells into adipocytes, thus
influencing adipose tissue growth and homeo-
stasis (Bart Deplancke, unpublished results). In
breast cancer tissues, spatial analysis of multi-
plex protein expression by imaging mass cytom-
etry (Giesen et al., 2014) allowed classification
of infiltrating immune cells and malignant cells
based on the neighborhood of surrounding cells,
highlighting new functional interactions (Bernd
Bodenmiller, personal communication).
A user’s guide to the Human Cell
Atlas: applications in research and
medicine
The Human Genome Project had a major impact
on biomedicine by providing a comprehensive
reference, a DNA sequence in which answers
could be readily looked up and from which
unique ’signatures’ could be derived (e.g., to
recognize genes on microarrays or protein frag-
ments in mass spectrometry). A Human Cell
Atlas could provide similar benefits from basic
research to clinically relevant applications.
Scientists will be able, for example, to look
up precisely in which cell types a gene of interest
is expressed and at which level. Today, it is sur-
prisingly challenging to obtain definitive answers
for most human genes beyond tissue- or organ-
level resolution, although there have been pio-
neering efforts for the brain and immune system
in mouse (Bakken et al., 2016;
Hawrylycz et al., 2012; Kim and Lanier, 2013;
Miller et al., 2014) and for protein expression in
human (Thul et al., 2017; Uhle´n et al., 2015).
Yet, the question is of enormous importance to
basic biologists studying development or
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comparing a model system to human biology,
medical scientists examining the effect of a dis-
ease-causing mutation, and drug developers
concerned about the potential toxicities of a
small molecule or a CAR-T cell targeting a spe-
cific protein (Brudno and Kochenderfer, 2016).
Researchers will also be able to derive
expression signatures that uniquely identify cell
types. Such signatures provide a starting point
for a vast range of experimental assays – from
molecular markers for isolating, tagging, tracing
or manipulating cells in animal models or human
samples, to characterization of the effect of
drugs on the physiological state of a tissue. Such
descriptors of cellular identity will be widely
used in clinical assays. For example, today’s
Complete Blood Count (CBC), a census of a lim-
ited number of blood components, may be sup-
plemented by a ’CBC 2.0’ that provides a high-
resolution picture of the nucleated cells, includ-
ing the number and activity states of each type
in comparison with healthy reference samples.
Analogous measures should be possible for
other tissues as well. For example, gut biopsies
from patients with ulcerative colitis or colon can-
cer could be analyzed for the type, response,
state and location of each of the diverse epithe-
lial, immune, stromal and neural cells that com-
prise them.
Toward a Human Cell Atlas
How might the biomedical community build a
Human Cell Atlas? As with the Human Genome
Project, a robust plan will best emerge from
wide-ranging scientific discussions and careful
planning involving biologists, technologists,
pathologists, physicians, surgeons, computa-
tional scientists, statisticians, and others. As
noted above, various discussions have taken
place for over two years about the idea of a
comprehensive Human Cell Atlas, as well as
about specific atlases for the brain and the
immune system. Several pilot efforts are already
underway. Moreover, over the past year discus-
sions have been underway to create an initial
plan for a Human Cell Atlas Project (which is
articulated in the White Paper mentioned
above). Among the key points for consideration
are the following:
Phasing of goals
While the overall goal is to build a comprehen-
sive atlas with diverse molecular measurements,
spatial organization, and interpretation of cell
types, histology, development, physiology and
molecular mechanisms, it will be wise to set
intermediate goals for ’draft’ atlases at increas-
ing resolution, comprehensiveness, and depth of
interpretation. The value of a phased approach
was illustrated by the Human Genome Project,
which defined milestones along the way (genetic
maps, physical maps, rough-draft sequence, fin-
ished sequence) that held the project account-
able and provided immediate utility to the
scientific community.
Sampling strategies
While an adult human has ~2 x 1013 nucleated
cells, it is neither possible nor necessary to study
them all to recover the fine distinctions among
human cells. The key will be to combine sound
statistical sampling, biological enrichment purifi-
cation, and insights from studies of model
organisms. It is likely beneficial to apply an
adaptive, iterative approach with respect to
both the number of cells and depth of profiles,
as well as anatomical coverage and spatial reso-
lution in the tissue, with initial sparse sampling
driving decisions about further sampling. This
adaptive approach, termed a ’Sky Dive’, adjusts
as resolution increases (and is further described
in the HCA White Paper).
Such approaches can be facilitated by experi-
mental techniques that allow fast and inexpen-
sive ’banking’ of partially processed samples, to
which one can return for deeper analysis as
methods mature. Advances in handling fixed or
frozen tissues would further facilitate the process
(Box 1). With respect to depth of profiling,
recent studies suggest the utility of a mixed
strategy: relatively low coverage of the transcrip-
tome can identify many cell types reliably
(Heimberg et al., 2016; Shekhar et al., 2016)
and a smaller set of deep profiles can be help
interpret the low-coverage data to further
increase detection power. As a result, the ’Sky
Dive’ begins with large-scale uniform sampling,
follows with stratified sampling, and then
employs specialized sampling at lower
throughput.
Breadth of profiles
The atlas must combine two branches – a cellular
branch, focused on the properties of individual
cells, and a spatial branch, describing the histo-
logical organization of cells in the tissue. For the
cellular branch, massively parallel transcriptome
analysis of individual single cells or nuclei will
likely be the workhorse for efforts in the first few
years. However, other robust, high-throughput
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profiling methods are rapidly emerging, includ-
ing techniques for studying chromatin, genome
folding, and somatic mutations at single-cell res-
olution (Box 1). For the spatial branch, in situ
analysis of the spatial patterns of RNA, proteins,
and potentially epigenomics will be equally
important. While some of these methods are
already rapidly maturing, others will benefit from
focused development efforts, as well as from
cross-comparison among different techniques.
Fortunately, most can be applied to preserved
tissue specimens, allowing specimens collected
now to be analyzed later, as methods mature.
Biological scope
It will be important to consider the balance
among tissue samples from healthy individuals
at various stages; small cohorts of individuals
with diseases; and samples from model organ-
isms, where key developmental stages are more
accessible and manipulations more feasible.
Well-chosen pilot projects could help refine
strategies and galvanize communities of biologi-
cal experts. Some communities and projects
would be organized around organs (e.g., liver,
heart, brain), others around systems (e.g., the
immune system) or disease (e.g., cancer), the lat-
ter distributed across many organs and tissues.
As outlined in the HCA White Paper, the first
draft of the atlas might pursue roughly a dozen
organs and systems, each from up to 100 indi-
viduals, collected across 3–4 geographical sites;
each would be analyzed to obtain both cellular
and spatial data, by means of uniform to strati-
fied sampling. Tissue from post-mortem exami-
nation will play a key role, because it is the only
way to obtain samples from a single individual
across the entire body. These efforts will be
complemented, where possible, by biopsy or
resection material from healthy research partici-
pants, and by whole organs obtained from
deceased transplant donors after transplantation
organs have been harvested. In some cases,
such as the immune system, samples from indi-
viduals with a disease will be included to probe
different functional states of a system.
The full atlas, will ultimately describe at least
10 billion cells, covering all tissues, organs, and
systems. Specimens will come from both healthy
research participants and small cohorts of
patients with relevant diseases. The cells and tis-
sues will be studied using a broad range of tech-
niques, to obtain cellular and spatial
information, from samples designed to repre-
sent the world’s diversity. As with previous
genomic projects, the Human Cell Atlas will be
bounded in its resolution (with respect to the
rarity of cell types/states and the spatial resolu-
tion), its coverage of disease and diversity
(broadly representative but not obviating the
need for direct genetic and clinical studies), and
its functional assessment (to validate the exis-
tence of identified cells and facilitate – but not
perform – detailed functional characterization).
Model organisms
The Human Genome Project and the broader
scientific community benefitted from insights
learned from genome projects conducted in par-
allel in model organisms. These projects empow-
ered functional studies in model organisms,
ushered a new era of comparative genomics,
and provided important technical lessons. By
analogy, we envision that key ’sister’ atlases in
model organisms will be developed in parallel
and in coordination with the Human Cell Atlas.
These projects should not delay progress on the
human atlas (or vice versa), because current
techniques are already directly applicable to bio-
medical research on human samples.
In some cases, model organism atlases can
use techniques that are not possible in humans,
such as engineering animals to facilitate lineage
tracing. In many cases, the extensive validation
and functional follow-up studies that can be per-
formed in model organisms will help validate ’by
proxy’ conclusions drawn in the human atlas.
Finally, comparing the atlases across organisms
will provide invaluable lessons in evolution and
function.
Quality
In creating a reference map to be used by thou-
sands of investigators, it is critical to ensure that
the results are of high quality and technically
reproducible. This is especially important in view
of the inherent biological variation and expected
measurement noise. Substantial investment will
be needed in the development, comparison,
and dissemination of rigorous protocols, stand-
ards, and benchmarks. Both individual groups
and larger centers will likely have important roles
in defining and ensuring high quality. It will also
be important that the collected samples be
accompanied by excellent clinical annotations,
captured in consistent meta-data across the
atlas.
Tissue processing poses special challenges,
including the need for robust methods for disso-
ciating samples into single cells so as to preserve
all cell types, fixation for in situ methods, and
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freezing for transport. A related challenge is the
difference in the amenability of specific cell
types for different assays (T cells are very small
and yield lower quality scRNA-seq; the fat con-
tent in adipocyte is challenging for many spatial
methods; many neurons cannot currently be iso-
lated with their axons and dendrites from adult
tissue). Careful attention will also be needed to
data generation and computational analysis,
including validated standard operating proce-
dures for experimental methods, best practices,
computational pipelines, and benchmarking
samples and data sets to ensure comparability.
Global equity
Geographical atlases of the Earth were largely
developed to serve global power centers. The
Human Cell Atlas should be designed to serve
all people: it should span genders, ethnicities,
environments, and the global burden of diseases
– all of which are likely to affect the molecular
profiles of cells and must be characterized to
maximize the atlas’s benefits. The project itself
should encourage and support the participation
of scientists, research centers and countries from
around the globe, while recognizing the value of
respecting and learning from diverse popula-
tions, cultures, mores, beliefs, and traditions.
Open data
The Human Genome Project made clear the
power of open data that can be used by all and
freely combined with other datasets. A Human
Cell Atlas should similarly be an open endeavor,
to the full extent permitted by participants’
wishes and legal regulation. While the underly-
ing sequence data contains many polymor-
phisms that make it ’identifiable’, it should be
possible to map the data onto ’standard models’
of each gene to substantially mitigate this issue.
To make the atlas useful, it will be critical to
develop data platforms that can provide efficient
aggregation and storage, quality control, analyt-
ical software, and user-friendly portals.
Flexibility
A Human Cell Atlas Project should be intellectu-
ally and technologically flexible. The project
should embrace the fact that its biological goals,
experimental methods, computational
approaches, overall scale, and criteria for ’com-
pletion’ will evolve rapidly as insights and tools
develop. For historical context, it is useful to
remember that discussions about a Human
Genome Project began before the development
of automated DNA sequencing machines, the
polymerase chain reaction, or large-insert DNA
cloning, and the project drove technological
progress on many fronts. Moreover, the criteria
for a ’finished’ genome sequence were only
agreed upon during the last third of the project.
Impact on the scientific community
Large-scale efforts, such as a Human Cell Atlas,
must be careful to appropriately weigh the ben-
efits to science and individual scientists with the
potential costs. We consider the key benefits to
the broad scientific community to include: the
core scientific knowledge and discoveries that
will result from having a reference map; the
empowerment of scientists working across any
tissue or cell type to pursue their research more
precisely and effectively; the development, hard-
ening and dissemination of experimental techni-
ques and computational methods in the context
of big-data settings, all of which will be openly
shared; the inclusive and maximally open Human
Cell Atlas community, inviting participation by
all individual labs and research centers; and the
coordination of efforts that would otherwise be
unconnected, less extensive, and more
expensive.
At the same time, we must be aware of
potential pitfalls, including: premature restriction
to specific technologies or approaches, which
might limit innovation in a fast-moving field;
implicit restriction of participation, based on
available resources; and diversion of funding
from other research directions. The unique orga-
nization and community of the Human Cell Atlas
Project will tackle these potential challenges by
committing to open membership, to the open
and immediate data release with no restrictions,
and to open-source code for all computational
approaches. We hope that the new information
and technology generated will more than repay
the costs of the project by increasing the speed
and efficiency of biomedical research through-
out the scientific community.
Engagement with the non-scientific
community
The general public is a key stakeholder commu-
nity for the Human Cell Atlas. Proper public
engagement should involve many communities,
including interested members of the public, citi-
zen-scientists, schoolchildren, teachers and,
where appropriate, research participants.
Engagement will take diverse forms, including
traditional media, social media, video and,
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importantly, direct sharing of the project’s data.
Across all channels, it will be important to articu-
late the goals, principles and motivations of the
project. While explaining the intended benefits
to the public with respect to advancing disease
biology, drug discovery and diagnostics, it will
be equally important to avoid ’hype’: that is, we
need to avoid making promises and raising
expectations that are unrealistic in content or
timing.
Forward looking
Any data produced today will be easier, faster,
more accurate and cheaper to produce tomor-
row. Any intermediate milestones achieved dur-
ing the project will be supplanted by deeper,
broader, more accurate, and more comprehen-
sive successors within a few short years. How-
ever, as we define the goal of a Human Cell
Atlas Project, we should view it not as a final
product, but as a critical stepping-stone to a
future when the study of human biology and
medicine is increasing tractable.
Conclusion
The past quarter-century has shown again and
again the value of the scientific community join-
ing together in collaborative efforts to generate
and make freely available systematic information
resources to accelerate scientific and medical
progress in tens of thousands of laboratories
around the world. The Human Cell Atlas builds
on this rich tradition, extending it to the funda-
mental unit of biological organization: the cell.
Many challenges will arise along the way, but
we are confident that they can be met through
scientific creativity and collaboration. It is time
to begin.
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